Clinical Trials Browser

Phase 1/2 × Recurrence × ruxolitinib × Clear all

NCT05745714 2025-09-16

HEM-iSMART C

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma